Differentially expressed genes in response to amoxicillin in Helicobacter pylori analyzed by RNA arbitrarily primed PCR.

Clinical Pharmacology and Gastroenterology Unit, São Francisco University Medical School, Braganca Paulista, SP, Brazil.
FEMS Immunology & Medical Microbiology (Impact Factor: 3.08). 08/2007; 50(2):226-30. DOI: 10.1111/j.1574-695X.2006.00209.x
Source: PubMed


Because the molecular mechanism of amoxicillin resistance in Helicobacter pylori seems to be partially explained by several mutational changes in the pbp1A gene, the aim of the present study was to evaluate the gene expression pattern in response to amoxicillin in the Amx(R) Hardenberg strain using RNA arbitrarily primed PCR (RAP-PCR). In the experiments, c. 100 differentially expressed RAP-PCR products were identified using five arbitrary primers. The cDNAs that presented the highest levels of induction or repression were cloned and sequenced, and the sequences were compared with those present in databases using the blast search algorithm. The differential expression of the isolated cDNAs was confirmed by real-time PCR. The preliminary results showed that amoxicillin alters the expression of five cDNAs involved in biosynthesis, two involved with pathogenesis, four related to cell envelope formation, two involved in cellular processes, three related with transport and binding proteins, one involved with protein degradation, one involved with energy metabolism and seven hypothetical proteins. Further analysis of these cDNAs will allow a better comprehension of both the molecular mechanism(s) of amoxicillin resistance and the adaptative mechanism(s) used by H. pylori in the presence of this antibiotic.

Download full-text


Available from: Johannes Kusters, Sep 30, 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: A distributed job shop scheduling algorithm has been implemented in the LAN (local area network) environment. The algorithm is a good candidate for distributed implementation since much of the computation time required for a solution is expended in distributable portions of the algorithm. A distributed processing support system (DPSS) was developed to ease the implementation of this and future distributed algorithms. Preliminary results indicate considerable potential for reducing the computation time. Additional portions of the algorithm may be distributed to improve the results, and streamlining of the underlying communication mechanism of DPSS is underway
    No preview · Conference Paper · May 1991
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The fumarase is an enzyme that could be used as target in drug design to treat infections by Helicobacter pylori and Trypanosoma brucei. In the first step, homology modeling was employed to build the 3D structure of pig heart fumarase (FUM P). Then, Q-Site Finder program was used to identify the potential binding sites of FUM P and fumarase of Saccharomyces cerevisiae (FUM Y). Further, molecular docking of arylderivatives substituted at the aromatic ring with an electron withdrawing or donating groups were evaluated on FUM P and on FUM Y to validate the homology model. The homology model of FUM P showed a structure very similar (70.33 % of identity in sequence) to the crystal structure of FUM Y. Some active sites were identified by Q-Site Finder server on FUM P and on FUM Y which could correspond to sites A and B. The docking results showed that some compounds were bonded at the site A on FUM P and FUM Y being those with electron withdrawing groups with more affinity on FUM P, suggesting that electronic effects are the more important ones during the recognition process by FUM P.
    Full-text · Article · Jul 2007 · Journal of the Mexican Chemical Society
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The ability of clinicians to wage an effective war against many bacterial infections is increasingly being hampered by skyrocketing rates of antibiotic resistance. Indeed, antibiotic resistance is a significant problem for treatment of diseases caused by virtually all known infectious bacteria. The gastric pathogen Helicobacter pylori is no exception to this rule. With more than 50% of the world's population infected, H. pylori exacts a tremendous medical burden and represents an interesting paradigm for cancer development; it is the only bacterium that is currently recognized as a carcinogen. It is now firmly established that H. pylori infection is associated with diseases such as gastritis, peptic and duodenal ulceration and two forms of gastric cancer, gastric adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma. With such a large percentage of the population infected, increasing rates of antibiotic resistance are particularly vexing for a treatment regime that is already fairly complicated; treatment consists of two antibiotics and a proton pump inhibitor. To date, resistance has been found to all primary and secondary lines of antibiotic treatment as well as to drugs used for rescue therapy.
    Full-text · Article · Sep 2008 · Current Drug Therapy
Show more